Search research articles
Contact Us
Filters
Showing results (11-20 of 137) with videos related to
Page
of 14
Sort By:
Clinical Breast Cancer
|
January 17, 2018
Characteristics and Prognostic Factors for Patients With HER2-overexpressing Breast Cancer and Brain Metastases in the Era of HER2-targeted Therapy: An Argument for Earlier Detection
Aki Morikawa, Rui Wang, Sujata Patil, et al.
Annals of the Rheumatic Diseases
|
August 24, 2017
Successful treatment of arthritis induced by checkpoint inhibitors with tocilizumab: a case series
Sang Taek Kim, Jean Tayar, Van Anh Trinh, et al.
Neuro-Ophthalmology (Aeolus Press)
|
May 26, 2018
Metastatic Melanoma of the Optic Nerve Sheath
Neil M D'souza, Huy D Nguyen, Stacy V Smith, et al.
Cancers
|
November 14, 2023
Infliximab for Treatment of Immune Adverse Events and Its Impact on Tumor Response
Vishnupriyadevi Parvathareddy, Umut Selamet, Aditi A Sen, et al.
Journal for Immunotherapy of Cancer
|
May 12, 2018
Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson
Yinghong Wang, Hamzah Abu-Sbeih, Emily Mao, et al.
Kidney International Reports
|
January 16, 2026
Infliximab for Grade III or IV Immune Checkpoint Inhibitor Nephritis Clinical and Translational Evidence
Nada Youssef, Masroor Habeeb, Hong Chen, et al.
Cancer
|
October 29, 2019
Intracranial antitumor activity with encorafenib plus binimetinib in patients with melanoma brain metastases: A case series
Kourtney Holbrook, Jose Lutzky, Michael A Davies, et al.
Journal of Hematology & Oncology
|
September 7, 2016
Selective inhibition of autoimmune exacerbation while preserving the anti-tumor clinical benefit using IL-6 blockade in a patient with advanced melanoma and Crohn's disease: a case report
Marc Uemura, Van A Trinh, Cara Haymaker, et al.
Oncoimmunology
|
June 9, 2021
Incidence, predictors, and survival impact of acute kidney injury in patients with melanoma treated with immune checkpoint inhibitors: a 10-year single-institution analysis
Maen Abdelrahim, Omar Mamlouk, Heather Lin, et al.
Cancer Immunology Research
|
April 19, 2019
IL17A Blockade Successfully Treated Psoriasiform Dermatologic Toxicity from Immunotherapy
Daniel Johnson, Anisha B Patel, Marc I Uemura, et al.
Page
of 14
Search research articles
Search
Showing results (11-20 of 137) with videos related to
Sort By:
Page
of 14
Clinical Breast Cancer
|
January 17, 2018
Characteristics and Prognostic Factors for Patients With HER2-overexpressing Breast Cancer and Brain Metastases in the Era of HER2-targeted Therapy: An Argument for Earlier Detection
Aki Morikawa, Rui Wang, Sujata Patil, et al.
Annals of the Rheumatic Diseases
|
August 24, 2017
Successful treatment of arthritis induced by checkpoint inhibitors with tocilizumab: a case series
Sang Taek Kim, Jean Tayar, Van Anh Trinh, et al.
Neuro-Ophthalmology (Aeolus Press)
|
May 26, 2018
Metastatic Melanoma of the Optic Nerve Sheath
Neil M D'souza, Huy D Nguyen, Stacy V Smith, et al.
Cancers
|
November 14, 2023
Infliximab for Treatment of Immune Adverse Events and Its Impact on Tumor Response
Vishnupriyadevi Parvathareddy, Umut Selamet, Aditi A Sen, et al.
Journal for Immunotherapy of Cancer
|
May 12, 2018
Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson
Yinghong Wang, Hamzah Abu-Sbeih, Emily Mao, et al.
Kidney International Reports
|
January 16, 2026
Infliximab for Grade III or IV Immune Checkpoint Inhibitor Nephritis Clinical and Translational Evidence
Nada Youssef, Masroor Habeeb, Hong Chen, et al.
Cancer
|
October 29, 2019
Intracranial antitumor activity with encorafenib plus binimetinib in patients with melanoma brain metastases: A case series
Kourtney Holbrook, Jose Lutzky, Michael A Davies, et al.
Journal of Hematology & Oncology
|
September 7, 2016
Selective inhibition of autoimmune exacerbation while preserving the anti-tumor clinical benefit using IL-6 blockade in a patient with advanced melanoma and Crohn's disease: a case report
Marc Uemura, Van A Trinh, Cara Haymaker, et al.
Oncoimmunology
|
June 9, 2021
Incidence, predictors, and survival impact of acute kidney injury in patients with melanoma treated with immune checkpoint inhibitors: a 10-year single-institution analysis
Maen Abdelrahim, Omar Mamlouk, Heather Lin, et al.
Cancer Immunology Research
|
April 19, 2019
IL17A Blockade Successfully Treated Psoriasiform Dermatologic Toxicity from Immunotherapy
Daniel Johnson, Anisha B Patel, Marc I Uemura, et al.
Page
of 14